RxDoctor Payments Data

Brian Port, MD

Family Medicine · Chester, VANPI 1336133602

Payments from drug & device makers

$167in general payments, 2019–2025

Across 12 payments — averaging $13.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$41
  • Takeda Pharmaceuticals U.S.A., Inc.$36
  • AbbVie$29
  • Amgen$16
  • Johnson & Johnson$15
  • Novo Nordisk$15
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$15996%
  • Education$74%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$167 in reported general payments places this provider in the 40th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$47,611
Medicare patients
212
Services billed
834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide52$52,391
TrulicityDulaglutide36$48,181
EliquisApixaban43$43,229
JardianceEmpagliflozin28$28,116
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$16,889
Breo ElliptaFluticasone/Vilanterol21$8,316
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,239
Combivent RespimatIpratropium/Albuterol Sulfate12$5,986
Arnuity ElliptaFluticasone Furoate14$3,912
Ezetimibe65$3,889
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$3,612
Atorvastatin Calcium344$2,792
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,612
Rosuvastatin Calcium219$2,304
Albuterol Sulfate HfaAlbuterol Sulfate60$1,888

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$52,39152 claims
Lilly USA, LLCTrulicity$41$48,18136 claims
AstraZenecaBreztri Aerosphere$14$16,88926 claims
AbbVieSynthroid$29$99727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Chester

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →